Department of Biological Science, College of Medical and Life Sciences, Silla University, 140 Baegyang-daero, 700beon-gil, Sasang-gu, Busan, 617-736, Korea.
Department of Periodontology, School of Dentistry, Pusan National University, 49 Busandaehak-ro, Mulgeum-eup, Yangsan, Gyeongsangnam-do, 626-870, Korea.
Naunyn Schmiedebergs Arch Pharmacol. 2021 Jan;394(1):59-71. doi: 10.1007/s00210-020-01958-3. Epub 2020 Aug 11.
Nifedipine, a calcium channel blocker, has been reported to possess anti-inflammatory and immunosuppressive effects. The current study was undertaken to explore the influence of nifedipine on the generation of proinflammatory mediators by murine macrophages activated by lipopolysaccharide (LPS) prepared from Prevotella intermedia, a putative periodontal pathogen, and associated mechanisms of action as well. LPS was purified by employing phenol-water extraction protocol. Culture supernatants were analyzed for nitric oxide (NO) and interleukin (IL)-1β. Real-time PCR and immunoblotting were conducted to quantify mRNA and protein expression, respectively. NF-κB-dependent secreted embryonic alkaline phosphatase (SEAP) levels were estimated by reporter assay. Nifedipine markedly suppressed the generation of iNOS-derived NO and IL-1β together with their mRNA expressions in murine macrophages activated by P. intermedia LPS. LPS-stimulated cells exposed to nifedipine notably increased the mRNA levels of Arg-1, Ym-1, FIZZ1, and TGF-β, which are typical markers for M2 macrophage polarization. Nifedipine induced HO-1 at both gene and protein levels in cells challenged with P. intermedia LPS, and the nifedipine-mediated inhibition of NO generation was significantly abrogated by adding SnPP, an HO-1 inhibitor. Nifedipine inhibited LPS-evoked generation of NO and IL-1β in a PPAR-γ-independent manner. In addition, NF-κB activation as well as phosphorylation of STAT1/3 induced by P. intermedia LPS was suppressed by nifedipine. Nifedipine is an inhibitor of P. intermedia LPS-evoked production of NO and IL-1β in murine macrophages and encourages macrophage polarization toward the M2 phenotype. Nifedipine possibly has potential to be used for host modulation of periodontal disease and is worth being further researched.
硝苯地平是一种钙通道阻滞剂,据报道具有抗炎和免疫抑制作用。本研究旨在探讨硝苯地平对牙周病潜在病原体中间普氏菌脂多糖(LPS)激活的小鼠巨噬细胞产生促炎介质的影响及其作用机制。采用酚-水提取法对 LPS 进行纯化。通过酶联免疫吸附试验(ELISA)检测培养上清液中一氧化氮(NO)和白细胞介素(IL)-1β的水平。实时定量 PCR 和免疫印迹法分别用于定量检测 mRNA 和蛋白表达。通过报告基因检测 NF-κB 依赖性分泌型碱性磷酸酶(SEAP)水平。硝苯地平显著抑制中间普氏菌 LPS 激活的小鼠巨噬细胞中 iNOS 衍生的 NO 和 IL-1β的产生及其 mRNA 表达。与 LPS 刺激的细胞相比,暴露于硝苯地平的 LPS 刺激细胞显著增加了 Arg-1、Ym-1、FIZZ1 和 TGF-β的 mRNA 水平,这些是 M2 巨噬细胞极化的典型标志物。硝苯地平在中间普氏菌 LPS 刺激的细胞中诱导 HO-1 的基因和蛋白水平,HO-1 抑制剂 SnPP 显著削弱了硝苯地平介导的 NO 生成抑制作用。硝苯地平以 PPAR-γ 非依赖性方式抑制 LPS 诱导的 NO 和 IL-1β的产生。此外,硝苯地平抑制中间普氏菌 LPS 诱导的 NF-κB 激活和 STAT1/3 磷酸化。硝苯地平是中间普氏菌 LPS 诱导的小鼠巨噬细胞中 NO 和 IL-1β产生的抑制剂,并促进巨噬细胞向 M2 表型极化。硝苯地平可能具有用于宿主调节牙周病的潜力,值得进一步研究。